Document is current
Any future updates will be listed below
-
Authors
Wright, Miranda L. https://orcid.org/0000-0002-0030-8385
Sundar, Krishna M.
Herrick, Jennifer S.
Barkmeier-Kraemer, Julie M.
-
Funding
Funding for this research was provided by:
National Center for Advancing Translational Sciences (8UL1TR000105)
- License Information
-
More Information
Article History
Received: 18 May 2021
Accepted: 16 September 2021
First Online: 30 September 2021
Declarations
:
: Miranda L. Wright: Financial: none; Non-financial: ASHA Member, ASHA SIG 3 member. Krishna M. Sundar: Non-financial (only equipment) support for study of sham vs. regular CPAP in chronic cough (Respironics Inc.); Site PI for study of iVAPS EPAP algorithm (Resmed Inc.); Co-founder, Hypnoscure LLC (no monies) through the University of Utah Technology Commercialization Office; Advisory board, Merck Inc. (on novel therapeutics for chronic refractory cough). Jennifer S. Herrick: Financial: Employed by the University of Utah and the Biostatistics Center that supported this work. Julie M. Barkmeier-Kraemer: Financial: Employed by the University of Utah, Clinic Director of the Utah Health Voice Disorders Center; Non-financial: ASHA Member, ASHA SIG 3 member.
: This study was approved by the University of Utah Institutional Review Board (IRB Protocol #00114102).
: All participants gave consent to participate prior to completing questionnaires or telephone interviews.
: All authors have contributed to the writing of this manuscript and have reviewed the manuscript being submitted.
